D-1324-2022 Class II Terminated
FDA drug recall D-1324-2022 was initiated by Mckesson Medical-Surgical Inc. Corporate Office on Jun 29, 2022 and is designated Class II. Reason for recall: CGMP Deviations: products were stored outside the drug label specifications. The recall status is terminated (terminated Feb 13, 2024). Affected quantity: 1 box.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 17, 2022
- Initiation Date
- Jun 29, 2022
- Termination Date
- Feb 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1 box
Product Description
Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.
Reason for Recall
CGMP Deviations: products were stored outside the drug label specifications.
Distribution Pattern
Nationwide in the USA.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1324-2022
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026